SGLT2 inhibitors and CV safety4. 25 No BENEFIT Answer 25% . WHAT IS THE % RELATIVE RISK REDUCTION...
31
SGLT2 inhibitors and CV safety4. 25 No BENEFIT Answer 25% . WHAT IS THE % RELATIVE RISK REDUCTION WITH SGLT2 INHIBITORS FOR END STAGE RENAL DISEASE 2. 3. 4. ... 17160 10142 7020 0.3